HEADER TRANSPORT PROTEIN 17-MAR-26 11XY TITLE ESCHERICHIA COLI MURJ IN THE OUTWARD-FACING CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPID II FLIPPASE MURJ; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PEPTIDOGLYCAN BIOSYNTHESIS PROTEIN MURJ; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: MURJ, MVIN, YCEN, B1069, JW1056; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIPID II FLIPPASE, PEPTIDOGLYCAN BIOSYNTHESIS, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.E.LI,W.M.CLEMONS REVDAT 1 16-SEP-26 11XY 0 JRNL AUTH Y.E.LI,G.F.BARON,W.M.CLEMONS JR. JRNL TITL STRUCTURES OF THE LIPID II FLIPPASE FROM THE MONODERM JRNL TITL 2 PATHOGEN STAPHYLOCOCCUS AUREUS. JRNL REF J.BIOL.CHEM. 13516 2026 JRNL REFN ESSN 1083-351X JRNL PMID 42700959 JRNL DOI 10.1016/J.JBC.2026.113516 REMARK 2 REMARK 2 RESOLUTION. 3.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, COOT, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 9NU4 REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.900 REMARK 3 NUMBER OF PARTICLES : 72314 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 11XY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAR-26. REMARK 100 THE DEPOSITION ID IS D_1000306040. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : E. COLI MURJ REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 4.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PHE A 501 REMARK 465 LYS A 502 REMARK 465 VAL A 503 REMARK 465 LYS A 504 REMARK 465 GLU A 505 REMARK 465 PHE A 506 REMARK 465 ALA A 507 REMARK 465 ARG A 508 REMARK 465 ARG A 509 REMARK 465 THR A 510 REMARK 465 VAL A 511 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 221 -7.97 59.52 REMARK 500 LYS A 406 -136.47 56.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 11XX RELATED DB: PDB REMARK 900 RELATED ID: EMD-76175 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-76176 RELATED DB: EMDB REMARK 900 ESCHERICHIA COLI MURJ IN THE OUTWARD-FACING CONFORMATION DBREF 11XY A 1 511 UNP P0AF16 MURJ_ECOLI 1 511 SEQRES 1 A 511 MET ASN LEU LEU LYS SER LEU ALA ALA VAL SER SER MET SEQRES 2 A 511 THR MET PHE SER ARG VAL LEU GLY PHE ALA ARG ASP ALA SEQRES 3 A 511 ILE VAL ALA ARG ILE PHE GLY ALA GLY MET ALA THR ASP SEQRES 4 A 511 ALA PHE PHE VAL ALA PHE LYS LEU PRO ASN LEU LEU ARG SEQRES 5 A 511 ARG ILE PHE ALA GLU GLY ALA PHE SER GLN ALA PHE VAL SEQRES 6 A 511 PRO ILE LEU ALA GLU TYR LYS SER LYS GLN GLY GLU ASP SEQRES 7 A 511 ALA THR ARG VAL PHE VAL SER TYR VAL SER GLY LEU LEU SEQRES 8 A 511 THR LEU ALA LEU ALA VAL VAL THR VAL ALA GLY MET LEU SEQRES 9 A 511 ALA ALA PRO TRP VAL ILE MET VAL THR ALA PRO GLY PHE SEQRES 10 A 511 ALA ASP THR ALA ASP LYS PHE ALA LEU THR SER GLN LEU SEQRES 11 A 511 LEU LYS ILE THR PHE PRO TYR ILE LEU LEU ILE SER LEU SEQRES 12 A 511 ALA SER LEU VAL GLY ALA ILE LEU ASN THR TRP ASN ARG SEQRES 13 A 511 PHE SER ILE PRO ALA PHE ALA PRO THR LEU LEU ASN ILE SEQRES 14 A 511 SER MET ILE GLY PHE ALA LEU PHE ALA ALA PRO TYR PHE SEQRES 15 A 511 ASN PRO PRO VAL LEU ALA LEU ALA TRP ALA VAL THR VAL SEQRES 16 A 511 GLY GLY VAL LEU GLN LEU VAL TYR GLN LEU PRO HIS LEU SEQRES 17 A 511 LYS LYS ILE GLY MET LEU VAL LEU PRO ARG ILE ASN PHE SEQRES 18 A 511 HIS ASP ALA GLY ALA MET ARG VAL VAL LYS GLN MET GLY SEQRES 19 A 511 PRO ALA ILE LEU GLY VAL SER VAL SER GLN ILE SER LEU SEQRES 20 A 511 ILE ILE ASN THR ILE PHE ALA SER PHE LEU ALA SER GLY SEQRES 21 A 511 SER VAL SER TRP MET TYR TYR ALA ASP ARG LEU MET GLU SEQRES 22 A 511 PHE PRO SER GLY VAL LEU GLY VAL ALA LEU GLY THR ILE SEQRES 23 A 511 LEU LEU PRO SER LEU SER LYS SER PHE ALA SER GLY ASN SEQRES 24 A 511 HIS ASP GLU TYR ASN ARG LEU MET ASP TRP GLY LEU ARG SEQRES 25 A 511 LEU CYS PHE LEU LEU ALA LEU PRO SER ALA VAL ALA LEU SEQRES 26 A 511 GLY ILE LEU SER GLY PRO LEU THR VAL SER LEU PHE GLN SEQRES 27 A 511 TYR GLY LYS PHE THR ALA PHE ASP ALA LEU MET THR GLN SEQRES 28 A 511 ARG ALA LEU ILE ALA TYR SER VAL GLY LEU ILE GLY LEU SEQRES 29 A 511 ILE VAL VAL LYS VAL LEU ALA PRO GLY PHE TYR SER ARG SEQRES 30 A 511 GLN ASP ILE LYS THR PRO VAL LYS ILE ALA ILE VAL THR SEQRES 31 A 511 LEU ILE LEU THR GLN LEU MET ASN LEU ALA PHE ILE GLY SEQRES 32 A 511 PRO LEU LYS HIS ALA GLY LEU SER LEU SER ILE GLY LEU SEQRES 33 A 511 ALA ALA CYS LEU ASN ALA SER LEU LEU TYR TRP GLN LEU SEQRES 34 A 511 ARG LYS GLN LYS ILE PHE THR PRO GLN PRO GLY TRP MET SEQRES 35 A 511 ALA PHE LEU LEU ARG LEU VAL VAL ALA VAL LEU VAL MET SEQRES 36 A 511 SER GLY VAL LEU LEU GLY MET LEU HIS ILE MET PRO GLU SEQRES 37 A 511 TRP SER LEU GLY THR MET PRO TRP ARG LEU LEU ARG LEU SEQRES 38 A 511 MET ALA VAL VAL LEU ALA GLY ILE ALA ALA TYR PHE ALA SEQRES 39 A 511 ALA LEU ALA VAL LEU GLY PHE LYS VAL LYS GLU PHE ALA SEQRES 40 A 511 ARG ARG THR VAL HELIX 1 AA1 ASN A 2 PHE A 32 1 31 HELIX 2 AA2 GLY A 35 ALA A 56 1 22 HELIX 3 AA3 PHE A 60 GLN A 75 1 16 HELIX 4 AA4 GLY A 76 ALA A 105 1 30 HELIX 5 AA5 ALA A 105 ALA A 114 1 10 HELIX 6 AA6 GLY A 116 ASP A 119 5 4 HELIX 7 AA7 THR A 120 PHE A 135 1 16 HELIX 8 AA8 PRO A 136 TRP A 154 1 19 HELIX 9 AA9 PHE A 157 ALA A 178 1 22 HELIX 10 AB1 ALA A 179 PHE A 182 5 4 HELIX 11 AB2 PRO A 184 VAL A 186 5 3 HELIX 12 AB3 LEU A 187 TYR A 203 1 17 HELIX 13 AB4 GLN A 204 LYS A 210 1 7 HELIX 14 AB5 ASP A 223 LEU A 257 1 35 HELIX 15 AB6 GLY A 260 SER A 297 1 38 HELIX 16 AB7 ASN A 299 LEU A 328 1 30 HELIX 17 AB8 LEU A 328 PHE A 337 1 10 HELIX 18 AB9 THR A 343 VAL A 359 1 17 HELIX 19 AC1 GLY A 360 SER A 376 1 17 HELIX 20 AC2 ILE A 380 ILE A 402 1 23 HELIX 21 AC3 LYS A 406 GLN A 432 1 27 HELIX 22 AC4 GLY A 440 MET A 466 1 27 HELIX 23 AC5 THR A 473 LEU A 499 1 27 CISPEP 1 ASN A 183 PRO A 184 0 -6.40 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 138 0 0 23 0 0 0 6 3792 1 0 40 END